| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ |
|---|---|---|---|---|---|
| Revenue | $6.7B | $3.3B | $3.2B | $-0.4B | $8.8B |
| Cost of Revenue | — | — | — | — | — |
| Gross Profit | — | — | — | — | — |
| R&D Expense | — | — | — | — | — |
| SG&A Expense | — | — | — | — | — |
| Operating Income | — | — | — | — | — |
| Net Income | $0.0B | $0.9B | $0.9B | $-0.7B | $3.2B |
| EPS (Basic) | $-0.24 | $11.86 | $10.99 | $-8.48 | $33.86 |
| EPS (Diluted) | $-0.24 | $11.74 | $10.76 | $-8.48 | $33.69 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ |
|---|---|---|---|---|---|
| Total Assets | $352.6B | $338.4B | $330.3B | $311.1B | $375.5B |
| Current Assets | — | — | — | — | — |
| Cash & Equivalents | $5.7B | $3.8B | $2.7B | $4.3B | $2.6B |
| Total Liabilities | $342.2B | $328.5B | $319.9B | $301.9B | $364.4B |
| Current Liabilities | — | — | — | — | — |
| Stockholders' Equity | $10.0B | $9.8B | $10.2B | $8.4B | $10.4B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ |
|---|---|---|---|---|---|
| Operating Cash Flow | $5.8B | $5.8B | $5.3B | $5.2B | $5.7B |
| Investing Cash Flow | $-7.8B | $-7.1B | $-0.6B | $-1.4B | $-1.3B |
| Capital Expenditures | — | — | — | — | — |
| Financing Cash Flow | $3.9B | $2.4B | $-6.3B | $-2.2B | $-3.8B |